ECSP003769A - NEW COMPOSITION AND USE - Google Patents
NEW COMPOSITION AND USEInfo
- Publication number
- ECSP003769A ECSP003769A ECSP003769A ECSP003769A EC SP003769 A ECSP003769 A EC SP003769A EC SP003769 A ECSP003769 A EC SP003769A EC SP003769 A ECSP003769 A EC SP003769A
- Authority
- EC
- Ecuador
- Prior art keywords
- new composition
- thiazolidinedione
- pharmaceutically acceptable
- acceptable carrier
- pharmaceutical composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 abstract 2
- 229940123464 Thiazolidinedione Drugs 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 abstract 1
- 229960004329 metformin hydrochloride Drugs 0.000 abstract 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Se dsecribe una composición farmacéutica que comprende una tiazolidinadiona, tal como compuesto (I), hidrocloruro de metfornina y un vehículo farmacéuticamente aceptable, en la que la tiazolidinadiona y el hidrocloruro de metformina están cada uno de ellos dispersado dentro de su propio vehículo farmacéuticamente aceptable en la ciomposición farmacéutica, y el uso de una composición de esta clase en medicina.A pharmaceutical composition comprising a thiazolidinedione is described, such as compound (I), metfornine hydrochloride and a pharmaceutically acceptable carrier, in which the thiazolidinedione and metformin hydrochloride are each dispersed within their own pharmaceutically acceptable carrier in the pharmaceutical composition, and the use of such a composition in medicine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9927119.9A GB9927119D0 (en) | 1999-11-16 | 1999-11-16 | Novel composition and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003769A true ECSP003769A (en) | 2002-06-26 |
Family
ID=10864629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003769 ECSP003769A (en) | 1999-11-16 | 2000-11-16 | NEW COMPOSITION AND USE |
Country Status (4)
| Country | Link |
|---|---|
| CN (2) | CN1939303A (en) |
| EC (1) | ECSP003769A (en) |
| GB (1) | GB9927119D0 (en) |
| ZA (1) | ZA200203865B (en) |
-
1999
- 1999-11-16 GB GBGB9927119.9A patent/GB9927119D0/en not_active Ceased
-
2000
- 2000-11-16 EC ECSP003769 patent/ECSP003769A/en unknown
- 2000-11-16 CN CN 200610100658 patent/CN1939303A/en active Pending
- 2000-11-16 CN CN 200510091017 patent/CN1736377A/en active Pending
-
2002
- 2002-05-15 ZA ZA200203865A patent/ZA200203865B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200203865B (en) | 2002-11-22 |
| CN1736377A (en) | 2006-02-22 |
| CN1939303A (en) | 2007-04-04 |
| GB9927119D0 (en) | 2000-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26439A1 (en) | NEW COMPOSITION AND USE | |
| PA8539901A1 (en) | NOVEDOUS O-DESMETIL-VENLAFAXINE SUCCINATE SALT | |
| AR019507A1 (en) | USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES | |
| CO5011096A1 (en) | MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS | |
| ECSP055738A (en) | ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ- [b, f] -AZEPIN-5-CARBOXAMIDE AND ITS NEW GLASS FORMS | |
| ID27504A (en) | NEW ORAL FORMULATION | |
| TR200200795T2 (en) | Piperazine derivatives as 5-HT1B antagonists | |
| AR035500A1 (en) | USE OF CLORPROMAZINE AND PENTAMIDINE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PACKAGE THAT INCLUDE CHLORPROMAZINE AND PENTAMIDINE. | |
| UY27760A1 (en) | NEW DERIVATIVES OF PIRROLIDINIO. | |
| DE60038183D1 (en) | COMPOUNDS AND COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | |
| DE60312523D1 (en) | ORAL, PHARMACEUTICAL PHARMACEUTICAL FORMS OF LIQUID MEDICAMENTS WITH IMPROVED BIOVERABILITY | |
| ECSP055701A (en) | NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME | |
| EE200000595A (en) | Delivery of the active ingredient to the carrier matrix | |
| DE60019334D1 (en) | ANTIVIRAL ARZNEI | |
| ECSP034766A (en) | A COMBINATION THAT INCLUDES COMBRETASTATINE AND ANTI-BANERIGINAL AGENTS | |
| AR023510A1 (en) | A TEAM OF PARTS, PHARMACEUTICAL FORMULATION AND USE OF A THROMBIN INHIBITOR. | |
| BR0112847A (en) | Use of a solid dosage form | |
| NO20014855D0 (en) | N- (2-phenyl-4-aminobutyl) -1-naphthamides as neurokinin-1 receptor antagonists | |
| ES2193007T1 (en) | STABLE PHARMACEUTICAL FORMULATION THAT INCLUDES MODIFICATION II OF TORSEMIDA. | |
| UY26329A1 (en) | VITRONECTIN RECEPTOR ANTAGONISTS | |
| ECSP941088A (en) | COMPOSITIONS | |
| AR040764A1 (en) | PHARMACEUTICAL FORMULATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLFEDRINE | |
| BR0111018A (en) | Liquid and solid stable formulations | |
| DK1155014T3 (en) | New benzimidazole compounds for use as active therapeutic agents, processes for the preparation of these compounds and pharmaceutical compositions comprising them | |
| ECSP034463A (en) | PHARMACEUTICAL COMPOSITION |